Is Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring q2 or q3?

Is Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring q2 or q3? - (ADDADM) Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal that concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response. Review our Author Guidelines and submit your manuscript to DADM. more...